Condition: Atrial Fibrillation (AF) · Paroxysmal AF · Persistent Atrial Fibrillation · Sponsor: Abbott Medical Devices
The objective of this clinical investigation is to evaluate the feasibility, safety, and effectiveness of a concomitant procedure involving the Volt PFA System and Amulet 2 device in patients indicated for both AF ablation and percutaneous LAAO.
This description comes directly from the study's public registry record.
Abeer Madbouly, Ph. D · 651-497-5099 · abeer.madbouly@abbott.com
Always discuss trial participation with your own doctor first.
| UZ Brussel | Brussels, B CAP R, Belgium | Recruiting |
| Motol and Homolka University Hospital | Prague, Czech Republic, Czechia | Recruiting |
| Rigshospitalet | Copenhagen, Copenha, Denmark | Recruiting |
| Cardioangiologisches Centrum am Bethanien Krankenhaus | Frankfurt am Main, Hesse, Germany | Recruiting |
| Universitätsklinikum Schleswig-Holstein - Campus Lübeck | Lübeck, Schlesw, Germany | Recruiting |
| Deutsches Herzzentrum der Charite | Berlin, State of Berlin, Germany | Recruiting |
| Mater Private Hospital | Dublin, Dublin, Ireland | Recruiting |
| Centro Cardiologico Monzino | Milan, Italy, Italy | Recruiting |
| ASST Grande Ospedale Metropolitano | Milan, Lombard, Italy | Recruiting |
| Vilnius University Hospital Santaros Klinikos | Vilnius, Dzukija, Lithuania | Recruiting |
| Slaskie Centrum Chorob Serca | Zabrze, Silesian Voivodeship, Poland | Not Yet Recruiting |
| Centralny Szpital Kliniczny Uniwersytetu | Lodz, Poland | Not Yet Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07523620